In this episode, Ajay Goel, PhD, AGAF, Professor and Chair, Department of Molecular Diagnostics and Experimental Therapeutics, City of Hope, discusses a promising blood-based test that detected 81% of advanced precancerous colorectal lesions and explores how earlier detection could shift cancer care toward prevention. He also examines screening access, reimbursement, follow-up care and the growing role of liquid biopsies in the future of oncology.
Dr. Ajay Goel on Blood-Based Screening and the Next Frontier of Cancer Prevention
Next Up in Becker's Healthcare Podcast Episodes
-
In this episode, Dr. Sam Patel, healthcare business consultant and CEO of Astra Culture and Looped, discusses the growing gap…
-
In this episode, Hunter Foster, VP, Agency Operations and Strategy, benefitbay, explores the growing adoption of ICHRA and defined contribution…
-
In this episode, Albert L. Wright, Jr., President and Chief Executive Officer of West Virginia University Health System, joins the…
Comments are closed.